IL85689A - Compositions for reducing blood cholesterol levels - Google Patents

Compositions for reducing blood cholesterol levels

Info

Publication number: IL85689A
Authority: IL; Israel
Prior art keywords: cholesterol levels; compositions; blood cholesterol; reducing blood; administered orally
Prior art date: 1987-03-24

Application number

IL85689A

Other languages

English (en)

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-24

Filing date

1988-03-10

Publication date

1993-05-13

1988-03-10 Application filed by Procter & Gamble filed Critical Procter & Gamble

1993-05-13 Publication of IL85689A publication Critical patent/IL85689A/xx

Links

HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 4
239000008280 blood Substances 0.000 title abstract 2
210000004369 blood Anatomy 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
241001499741 Plantago arenaria Species 0.000 abstract 1
235000003421 Plantago ovata Nutrition 0.000 abstract 1
239000009223 Psyllium Substances 0.000 abstract 1
229920000728 polyester Polymers 0.000 abstract 1
229920005862 polyol Polymers 0.000 abstract 1
150000003077 polyols Chemical class 0.000 abstract 1
229940070687 psyllium Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Alternative & Traditional Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Biotechnology (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL85689A 1987-03-24 1988-03-10 Compositions for reducing blood cholesterol levels IL85689A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/029,825 US4849222A (en)	1987-03-24	1987-03-24	Mixtures for treating hypercholesterolemia

Publications (1)

Publication Number	Publication Date
IL85689A true IL85689A (en)	1993-05-13

Family

ID=21851092

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL85689A IL85689A (en)	1987-03-24	1988-03-10	Compositions for reducing blood cholesterol levels

Country Status (14)

Country	Link
US (1)	US4849222A (ja)
EP (1)	EP0285201B1 (ja)
JP (1)	JP2581737B2 (ja)
KR (1)	KR970004956B1 (ja)
AT (1)	ATE79544T1 (ja)
AU (1)	AU620541B2 (ja)
CA (1)	CA1314230C (ja)
DE (1)	DE3873800T2 (ja)
DK (1)	DK167847B1 (ja)
IE (1)	IE61404B1 (ja)
IL (1)	IL85689A (ja)
NZ (1)	NZ223947A (ja)
PH (1)	PH26694A (ja)
ZA (1)	ZA882061B (ja)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4579752A (en) *	1984-10-29	1986-04-01	At&T Bell Laboratories	Enhanced corrosion resistance of metal surfaces
JPH0788318B2 (ja) *	1986-08-06	1995-09-27	三菱レイヨン株式会社	イソブチレンの製造法
US5095008A (en) *	1987-09-14	1992-03-10	The Procter & Gamble Company	Cookies containing psyllium
US4950140A (en) *	1987-09-14	1990-08-21	The Procter & Gamble Company	Cookies containing psyllium
US5910317A (en) *	1988-01-11	1999-06-08	The Procter & Gamble Company	Mixed compositions for treating hypercholesterolemia
US4978529A (en) *	1988-05-25	1990-12-18	Denick Jr John	Easily dispersible psyllium compositions
US5149541A (en) *	1988-10-03	1992-09-22	The Procter & Gamble Company	Psyllium-containing produces with a distribution of particle size
US5026689A (en) *	1989-03-29	1991-06-25	General Mills, Inc.	R-T-E cereal with psyllium
US5024996A (en) *	1989-12-05	1991-06-18	General Mills, Inc.	R-T-E cereal with soluble fibers
US5219570A (en) *	1989-08-10	1993-06-15	The Procter & Gamble Company	Agglomerated psyllium husk containing edible acid
US6419911B1 (en)	1993-09-17	2002-07-16	Board Of Trustees Of Michigan State University	Psyllium containing snack bars, processes for making these, and uses thereof
US5126150A (en) *	1990-10-01	1992-06-30	The Procter & Gamble Company	Compositions containing psyllium
JPH06504281A (ja) *	1990-12-20	1994-05-19	ザ、プロクター、エンド、ギャンブル、カンパニー	改良された嗜好性を有するオオバコ及びコレスチラミン組成物
US5721221A (en) *	1991-03-08	1998-02-24	Regents Of The University Of Minnesota	Lowering blood cholesterol levels using water soluble cellulose ethers
AU3473193A (en) *	1992-01-17	1993-08-03	Procter & Gamble Company, The	Treatment for atherosclerosis
US5244887A (en) *	1992-02-14	1993-09-14	Straub Carl D	Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
US5281584A (en) *	1992-02-28	1994-01-25	The Dow Chemical Company	Effect of particle-size distribution of cellulose ethers on palatability of compositions
US5258181A (en) *	1992-03-02	1993-11-02	The Procter & Gamble Company	Compositions containing psyllium
WO1993017588A1 (en)	1992-03-11	1993-09-16	The Procter & Gamble Company	Psyllium drink mix compositions containing granulated base
WO1993018756A1 (en) *	1992-03-20	1993-09-30	The Procter & Gamble Company	Anion exchange resin compositions
US5232698A (en) *	1992-06-12	1993-08-03	The Proctor & Gamble Company	Psyllium drink mix compositions
US5234916A (en) *	1992-06-12	1993-08-10	The Proctor & Gamble Company	Psyllium drink mix compositions
US5338549A (en) *	1992-12-21	1994-08-16	The Procter & Gamble Company	Powdered psyllium drink mix compositions containing antioxidant
US5422101A (en) *	1993-05-14	1995-06-06	The Procter & Gamble Company	Cholesterol lowering drink mix compositions
US5384136A (en) *	1993-09-17	1995-01-24	Kellogg Company	Psyllium-enriched dough products and method for making the same
US5384144A (en) *	1993-09-17	1995-01-24	Kellogg Company	Psyllium enriched pasta products and method for making same
US5382443A (en) *	1993-09-17	1995-01-17	Kellogg Company	Ready-to-eat cereals containing extruded pre-wetted psyllium
US5955123A (en) *	1996-10-21	1999-09-21	The Procter & Gamble Company	Baked compositions comprising psyllium
US6358504B1 (en)	1997-02-07	2002-03-19	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
BR9814655A (pt)	1997-11-07	2000-10-03	Kellog Co	Produtos intermediários extrudados contendo fibras e produtos alimentares com os mesmos
US6123978A (en)	1998-08-31	2000-09-26	Mcneil-Ppc, Inc.	Stable salad dressings
WO2000027210A1 (en)	1998-11-05	2000-05-18	Kellogg Company	Psyllium enriched baked snack foods
US7892586B2 (en)	2001-02-22	2011-02-22	Suzanne Jaffe Stillman	Water containing soluble fiber
US7115297B2 (en) *	2000-02-22	2006-10-03	Suzanne Jaffe Stillman	Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7238380B2 (en) *	2000-02-22	2007-07-03	Suzanne Jaffe Stillman	Water containing soluble fiber
US8178150B2 (en)	2000-02-22	2012-05-15	Suzanne Jaffe Stillman	Water containing soluble fiber
CN100339070C (zh)	2002-10-24	2007-09-26	莫茨药物股份两合公司	包含1－氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物
UA80055C2 (en) *	2003-05-27	2007-08-10	Forest Laboratories	Combination of nmda-receptor antagonist and selective inhibitor of serotonin reuptake for a depression and other pscihiatric disorders treatment
JP2004352626A (ja) *	2003-05-28	2004-12-16	Asahi Breweries Ltd	植物由来成分を含有する抗コレステロール剤
AU2004316119B2 (en) *	2003-10-22	2008-04-24	Merz Pharma Gmbh & Co. Kgaa	The use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic AB peptides in amyloidopathies
TW200616608A (en) *	2004-07-09	2006-06-01	Forest Laboratories	Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
US20060079582A1 (en) *	2004-09-23	2006-04-13	Jeffrey Jonas	Memantine for the treatment of childhood behavioral disorders
US20060205822A1 (en) *	2004-12-22	2006-09-14	Forest Laboratories, Inc.	1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
KR100679290B1 (ko) *	2005-06-30	2007-02-05	박정휘	Ｈｇｄｓｊ201 생약 복합제 추출물을 포함하는 비만의예방 및 치료용 조성물
US8088382B2 (en) *	2005-07-05	2012-01-03	Cornell Research Foundation, Inc.	Methods of inhibiting transendothelial migration of neutrophils and monocytes with anti-CD99L2 antibodies
US7960139B2 (en)	2007-03-23	2011-06-14	Academia Sinica	Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
CN101801366A (zh)	2007-09-12	2010-08-11	莫茨药物股份两合公司	用于neramexane的逐步增量包装和其在治疗内耳病中的用途
EP2085120A1 (en)	2008-02-01	2009-08-05	Merz Pharma GmbH & Co. KGaA	The use of substances for the treatment of central or peripheral insulin receptor impairment and insulin resistance
DK2318832T3 (da)	2008-07-15	2014-01-20	Academia Sinica	Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder
TWI432188B (zh)	2008-12-19	2014-04-01	Merz Pharma Gmbh & Co Kgaa	供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類
WO2010069595A1 (en)	2008-12-19	2010-06-24	Merz Pharma Gmbh & Co. Kgaa	1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
WO2011000564A1 (en)	2009-06-30	2011-01-06	Merz Pharma Gmbh & Co. Kgaa	Eltoprazine for the treatment of drug addiction
WO2011000562A1 (en)	2009-06-30	2011-01-06	Merz Pharma Gmbh & Co. Kgaa	Eltoprazine for the treatment of certain movement disorders
WO2011000565A1 (en)	2009-06-30	2011-01-06	Merz Pharma Gmbh & Co. Kgaa	Eltoprazine for the treatment of anxiety
WO2011000563A1 (en)	2009-06-30	2011-01-06	Merz Pharma Gmbh & Co. Kgaa	Eltoprazine for the treatment of weight disorders
US10087236B2 (en)	2009-12-02	2018-10-02	Academia Sinica	Methods for modifying human antibodies by glycan engineering
US11377485B2 (en)	2009-12-02	2022-07-05	Academia Sinica	Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en)	2010-04-12	2011-10-20	Academia Sinica	Glycan arrays for high throughput screening of viruses
US20110294890A1 (en)	2010-05-28	2011-12-01	Merz Pharma Gmbh & Co. Kgaa	Neramexane for the treatment or prevention of inner ear disorders
US9109007B2 (en)	2010-08-18	2015-08-18	Purdue Pharma L.P.	MHC-I restricted epitopes containing non-natural amino acid residues
EP2665474A1 (en)	2011-01-20	2013-11-27	Merz Pharma GmbH & Co. KGaA	Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
WO2012171653A1 (en)	2011-06-15	2012-12-20	Merz Pharma Gmbh & Co. Kgaa	Sarizotan for use in the treatment of attention deficit hyperactivity disorder (adhd)
US10130714B2 (en)	2012-04-14	2018-11-20	Academia Sinica	Enhanced anti-influenza agents conjugated with anti-inflammatory activity
TW201412325A (zh)	2012-06-20	2014-04-01	梅茲製藥有限兩合公司	用於治療患有青光眼及其他退化性眼疾之人類視力喪失的間隔醫療
US9914956B2 (en)	2012-08-18	2018-03-13	Academia Sinica	Cell-permeable probes for identification and imaging of sialidases
WO2014210397A1 (en)	2013-06-26	2014-12-31	Academia Sinica	Rm2 antigens and use thereof
EP3013347B1 (en)	2013-06-27	2019-12-11	Academia Sinica	Glycan conjugates and use thereof
EP3041484B1 (en)	2013-09-06	2021-03-03	Academia Sinica	Human inkt cell activation using glycolipids with altered glycosyl groups
EP3046588B1 (en)	2013-09-17	2022-03-02	OBI Pharma, Inc.	Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
US10150818B2 (en)	2014-01-16	2018-12-11	Academia Sinica	Compositions and methods for treatment and detection of cancers
KR20160104727A (ko)	2014-01-16	2016-09-05	아카데미아 시니카	암의 치료 및 검출을 위한 조성물 및 방법
TWI797430B (zh)	2014-03-27	2023-04-01	中央研究院	反應性標記化合物及其用途
JP2017518989A (ja)	2014-05-27	2017-07-13	アカデミアシニカＡｃａｄｅｍｉａＳｉｎｉｃａ	抗ｃｄ２０糖操作抗体群およびその使用
US10118969B2 (en)	2014-05-27	2018-11-06	Academia Sinica	Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR20170010003A (ko)	2014-05-27	2017-01-25	아카데미아 시니카	박테로이드 기원의 푸코시다제 및 이의 사용 방법
EP4116329A1 (en)	2014-05-27	2023-01-11	Academia Sinica	Anti-her2 glycoantibodies and uses thereof
JP7063538B2 (ja)	2014-05-28	2022-05-09	アカデミアシニカ	抗ＴＮＦα糖操作抗体群およびその使用
EP3191500A4 (en)	2014-09-08	2018-04-11	Academia Sinica	HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US9975965B2 (en)	2015-01-16	2018-05-22	Academia Sinica	Compositions and methods for treatment and detection of cancers
US10495645B2 (en)	2015-01-16	2019-12-03	Academia Sinica	Cancer markers and methods of use thereof
AU2015378564A1 (en)	2015-01-24	2017-07-13	Academia Sinica	Novel glycan conjugates and methods of use thereof
EP3344806A4 (en)	2015-09-04	2019-03-20	OBI Pharma, Inc.	GLYCANARRAYS AND METHOD OF USE
CN109195996A (zh)	2016-03-08	2019-01-11	中央研究院	N-聚醣及其阵列的模组化合成方法
AU2017239637A1 (en)	2016-03-29	2018-11-15	Obi Pharma, Inc.	Antibodies, pharmaceutical compositions and methods
US10980894B2 (en)	2016-03-29	2021-04-20	Obi Pharma, Inc.	Antibodies, pharmaceutical compositions and methods
IL262296B2 (en)	2016-04-22	2024-09-01	Obi Pharma Inc	Cancer immunotherapy by immune activation or immune modulation via globo series antigens
KR20190067765A (ko)	2016-07-27	2019-06-17	오비아이 파머 인코퍼레이티드	면역원성/치료 글리칸 조성물 및 그의 용도
KR102528998B1 (ko)	2016-07-29	2023-05-03	오비아이 파머 인코퍼레이티드	인간 항체, 제약 조성물 및 방법
CA3034057A1 (en)	2016-08-22	2018-03-01	CHO Pharma Inc.	Antibodies, binding fragments, and methods of use
WO2018094414A1 (en)	2016-11-21	2018-05-24	Obi Pharma, Inc.	Conjugated biological molecules, pharmaceutical compositions and methods
TW202504930A (zh)	2018-06-27	2025-02-01	台灣浩鼎生技股份有限公司	用於糖蛋白工程的糖苷合成酶變體及其使用方法
EP3791873A1 (en)	2019-09-16	2021-03-17	Universite De Bordeaux	Methods of treatment and/or prevention of disorders and symptoms related to bkca and/or sk channelophathies

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2831854A (en) *	1955-05-24	1958-04-22	Procter & Gamble	Method for preparing fatty esters of non-reducing oligosaccharides in the presence of an amide
US3455714A (en) *	1964-09-01	1969-07-15	Hercules Inc	Cellulose derivatives of improved dispersibility and process
US3600186A (en) *	1968-04-23	1971-08-17	Procter & Gamble	Low calorie fat-containing food compositions
US3579548A (en) *	1968-05-10	1971-05-18	Procter & Gamble	Triglyceride esters of alpha-branched carboxylic acids
US3954976A (en) *	1973-12-14	1976-05-04	The Procter & Gamble Company	Pharmaceutical compositions for inhibiting absorption of cholesterol
US3963699A (en) *	1974-01-10	1976-06-15	The Procter & Gamble Company	Synthesis of higher polyol fatty acid polyesters
US4034083A (en) *	1975-11-03	1977-07-05	The Procter & Gamble Company	Compositions for inhibiting absorption of cholesterol
US4005196A (en) *	1976-02-12	1977-01-25	The Procter & Gamble Company	Vitaminized compositions for treating hypercholesterolemia
US4005195A (en) *	1976-02-12	1977-01-25	The Procter & Gamble Company	Compositions for treating hypercholesterolemia
IE44458B1 (en) *	1976-02-12	1981-12-02	Procter & Gamble	Compositions for treating hypercholesterolemia
US4241054A (en) *	1978-12-08	1980-12-23	The Procter & Gamble Company	Detoxifying lipophilic toxins
US4264583A (en) *	1979-07-25	1981-04-28	The Procter & Gamble Company	Gallstone dissolution compositions and method
US4382924A (en) *	1980-06-25	1983-05-10	The Procter & Gamble Company	Palatable composition containing oil or oil-like materials
DE3027611A1 (de) *	1980-07-21	1982-02-18	Bayer Ag, 5090 Leverkusen	Di- und oligo-1,2,4-triazolidin-3,5-dione und verfahren zu ihrer herstellung
US4321263A (en) *	1980-09-30	1982-03-23	Rowell Laboratories, Inc.	Psyllium compositions
US4461782A (en) *	1982-02-16	1984-07-24	The Procter & Gamble Company	Low calorie baked products
US4517360A (en) *	1983-06-23	1985-05-14	The Procter & Gamble Company	Synthesis of higher polyol fatty acid polyesters using carbonate catalysts
US4518772A (en) *	1983-06-23	1985-05-21	The Proctor & Gamble Company	Synthesis of higher polyol fatty acid polyesters using high soap:polyol ratios

1987
- 1987-03-24 US US07/029,825 patent/US4849222A/en not_active Expired - Fee Related
1988
- 1988-03-10 IL IL85689A patent/IL85689A/xx not_active IP Right Cessation
- 1988-03-14 DE DE8888200479T patent/DE3873800T2/de not_active Expired - Fee Related
- 1988-03-14 EP EP88200479A patent/EP0285201B1/en not_active Expired - Lifetime
- 1988-03-14 AT AT88200479T patent/ATE79544T1/de not_active IP Right Cessation
- 1988-03-18 NZ NZ223947A patent/NZ223947A/xx unknown
- 1988-03-23 IE IE87088A patent/IE61404B1/en not_active IP Right Cessation
- 1988-03-23 ZA ZA882061A patent/ZA882061B/xx unknown
- 1988-03-23 AU AU13521/88A patent/AU620541B2/en not_active Ceased
- 1988-03-23 JP JP63069220A patent/JP2581737B2/ja not_active Expired - Lifetime
- 1988-03-23 CA CA000562187A patent/CA1314230C/en not_active Expired - Fee Related
- 1988-03-23 PH PH36678A patent/PH26694A/en unknown
- 1988-03-24 DK DK162488A patent/DK167847B1/da not_active IP Right Cessation
- 1988-03-24 KR KR1019880003150A patent/KR970004956B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PH26694A (en)	1992-09-15
EP0285201A3 (en)	1990-01-24
JPS6426A (en)	1989-01-05
JP2581737B2 (ja)	1997-02-12
CA1314230C (en)	1993-03-09
DK162488A (da)	1988-09-25
KR880010764A (ko)	1988-10-24
US4849222A (en)	1989-07-18
DE3873800D1 (de)	1992-09-24
ATE79544T1 (de)	1992-09-15
AU620541B2 (en)	1992-02-20
KR970004956B1 (ko)	1997-04-10
DK162488D0 (da)	1988-03-24
AU1352188A (en)	1988-09-22
DK167847B1 (da)	1993-12-27
DE3873800T2 (de)	1993-01-14
ZA882061B (en)	1988-09-14
EP0285201B1 (en)	1992-08-19
IE61404B1 (en)	1994-11-02
NZ223947A (en)	1991-02-26
EP0285201A2 (en)	1988-10-05
IE880870L (en)	1988-09-24

Legal Events

Date	Code	Title	Description
1999-03-12	RH	Patent void

Publication	Publication Date	Title
NZ223947A (en)	1991-02-26	Composition and method for reducing blood cholesterol levels using psyllium seed gum and polyol polyester
AU590403B2 (en)	1989-11-02	Pharmaceutical composition for the treatment of periodontal diseases
DE3876054D1 (de)	1992-12-24	Psyllium enthaltende kuchen.
AU1857888A (en)	1989-01-27	Reduced base-content chewing gum compositions having anesthetic properties
AU7061687A (en)	1987-10-01	Pharmaceutical composition for treating periodontal diseases
EP0295721A3 (en)	1989-02-01	Promotion of healing of meniscal tissue
EP0277002A3 (en)	1988-10-26	Steroid-5-alpha-reductase inhibitors
AU2049788A (en)	1989-02-09	Skin care compositions
ZA872067B (en)	1987-11-25	Vaginal pharmaceutical composition
EP0334507A3 (en)	1991-04-17	Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid
AU1305588A (en)	1988-09-15	Skin care compositions
AU2181388A (en)	1989-03-09	Psyllium-containing filling compositions and methods
AU1336288A (en)	1988-09-29	Photopolymerizable dental composition
IE883878L (en)	1989-06-29	Mixed compositions for treating hypercholesterolemia
JPS646262A (en)	1989-01-10	Morpholine derivative, manufacture and medicinal composition
GB8810422D0 (en)	1988-06-08	Ophthalmological composition of matter
AU603892B2 (en)	1990-11-29	Photopolymerizable dental composition
ZA883744B (en)	1989-08-30	Promotion of healing of meniscal tissue
NZ240612A (en)	1994-06-27	Dietary compositions containing psyllium fibre and almond paste
EP0378824A3 (en)	1990-09-19	Use of omega-3-fatty acids as anticachexia agents
NZ220744A (en)	1989-07-27	6-substituted 1,2-methylenandrost-4-ene-3,17-diones and pharmaceutical compositions
NZ223293A (en)	1990-02-26	Beta-alkyl melatonins and pharmaceutical compositions
AU6913087A (en)	1987-09-03	Treatment of menopausal symptoms
JPS6442470A (en)	1989-02-14	Guanidinecarboxylic acid esters, manufacture and medicinal composition
JPS6438073A (en)	1989-02-08	Novel derivative of tetrahydropyridine, manufacture and intermediate, use as drug and medicinal composition